Annual Drug Patent Expirations for ONIVYDE
Onivyde is a drug marketed by Ipsen and is included in one NDA. It is available from one supplier. There are seventeen patents protecting this drug.
This drug has one hundred and twelve patent family members in twenty-eight countries.
The generic ingredient in ONIVYDE is irinotecan hydrochloride. One supplier is listed for this compound. Additional details are available on the irinotecan hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
